Cargando…
直接测序法和ARMS法检测非小细胞肺癌表皮生长因子受体基因突变的比较
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) inhibitors are mainly used for the targeted therapy of non-small cell lung cancer (NSCLC).Therefore, EGFR mutations should be detected to treat lung cancer.The aim of this study is to determine the detection rate of NSCLC in patients...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000363/ https://www.ncbi.nlm.nih.gov/pubmed/25130967 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.05 |
Ejemplares similares
-
变性高效液相色谱法检测多种途径获取的非小细胞肺癌组织表皮生长因子受体基因突变
Publicado: (2010) -
表皮生长因子受体突变细胞系H1650耐药机制探讨
Publicado: (2012) -
抗表皮生长因子受体和抗血管内皮生长因子药物在非小细胞肺癌治疗中的作用
por: LANGER, Corey, et al.
Publicado: (2010) -
表皮生长因子受体基因突变非小细胞肺癌的靶向治疗及其耐药机制
Publicado: (2022) -
微滴数字PCR和Super-ARMS检测晚期肺腺癌患者血浆循环肿瘤DNA表皮生长因子受体基因突变的临床价值研究
Publicado: (2020)